Award Year / Program / Phase:2011 / SBIR / Phase I
Agency:HHS
Principal Investigator:Daniel Paris – 941-755-6644
Award Amount:$150,000.00
Abstract:
DESCRIPTION (provided by applicant): The A2 peptide is widely thought to be implicated in the pathogenesis of Alzheimer's Disease (AD) and A2-lowering strategies are being pursued by most major pharmaceutical companies. Archer Pharmaceuticals Inc. (Archer) and the Roskamp Institute have⦠More